Morooka-cho, Kohoku-ku, Yokohama 222, Japan (Received for publication May 25, 1992) Fosfomycin (FM) is a clinically useful antibiotic produced by several Streptomyces species2'3*, Pseudomonas syringae^and Pseudomonas viridiflava5). This small compound has a unique structure, including a carbon-phosphorus bond (C-P bond) and an epoxide6). Recently we proved that the C-P bond in FM was formed by intramolecular rearrangement of phosphoenolpyruvate (PEP) to phosphonopyruvate catalyzed by PEP phosphomutase ( Fig. 1 (1))1} utilizing a mechanism commonto the formation of other natural C-P compounds such as bialaphos7), 2-aminoethylphosphonic acid8), 2-hydroxyethylphosphonic acid (HEP)9) and FR-332897).
By bioconversion experiments using two FM non-producing mutants of Streptomyces wedmorensis, NP-7 and A16, we also showed that the epoxide ring of FMwas formed by dehydrogenation of 2-hydroxypropylphosphonic acid (HPP)10'11*. Fig. 1 hours at 27°C, 14C labeled FM was partially purified according to the method reported previously4). The broth filtrate was adsorbed on a Dowex-1 (Cl~form) column and FMwas eluted with 5% NaCl solution. 
